BioCentury | Jun 29, 2019

All eyes on new modality launches, cancer and rare disease data in 3Q19 acquisition of TiGenix N.V. Alofisel darvadstrocel 3/23/18 NR NR NA NA Nipro Corp. (Tokyo:8086) Stemirac...
BioCentury | Mar 22, 2019
Product Development

Regulating regeneration in Europe

...granted condition approval to the cell therapy Stemirac based on clinical data from 13 patients. Stemirac...
BioCentury | Jan 25, 2019
Clinical News

Japan approves stem cell product for spinal cord injury

...Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional approval in December to Stemirac, an...
...based on data from a clinical trial in which 12 of 13 patients who received Stemirac... the Nature article. Nipro Corp. (Tokyo:8086), Osaka, Japan Sapporo Medical University, Sapporo, Japan Product: Stemirac...
Items per page:
1 - 3 of 3